nifekalant hydrochloride has been researched along with Renal Insufficiency in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamakura, S; Kawamura, A; Kurita, T; Miyazaki, S; Morii, I; Myoishi, M; Nonogi, H; Otsuka, Y; Satomi, K; Ueno, K; Yasuda, S | 1 |
1 other study(ies) available for nifekalant hydrochloride and Renal Insufficiency
| Article | Year |
|---|---|
Intravenous administration of nifekalant hydrochloride for the prevention of ischemia-induced ventricular tachyarrhythmia in patients with renal failure undergoing hemodialysis.
Topics: Aged; Anti-Arrhythmia Agents; Diabetic Nephropathies; Drug Monitoring; Electrocardiography; Humans; Injections, Intravenous; Male; Myocardial Ischemia; Pyrimidinones; Renal Dialysis; Renal Insufficiency; Tachycardia, Ventricular | 2003 |